supp.fit
All study protocols

Pueraria Mirifica: study protocols

13 study groups say how much Pueraria Mirifica participants took a day. These are the doses the studies gave. They are not a recommendation.

Pueraria Mirifica: what the research found →

Dose per serving from research

13 study groups in 6 studies say how much Pueraria Mirifica participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 62% of 13 study groups.

Daily doseStudy groups
10 mg to 25 mg
3
25 mg to 50 mg
8
50 mg to 100 mg
2

Commonly used together

None of these 13 study groups took Pueraria Mirifica with anything else.

13 study groups

Study
Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study
2007 · Group A · Perimenopausal women with climacteric symptoms
50 mg26 weeks30
Comparison of Pueraria mirifica 25 and 50 mg for menopausal symptoms
2011 · Arm A · Hysterectomized women with menopausal symptoms and an indication for hormone therapy
25 mg26 weeks26
Comparison of Pueraria mirifica 25 and 50 mg for menopausal symptoms
2011 · Arm B · Hysterectomized women with menopausal symptoms and an indication for hormone therapy
50 mg26 weeks26
Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study
2004 · Group A (50 mg/day) · Perimenopausal women with vasomotor symptoms
50 mg26 weeks20
Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study
2004 · Group B (100 mg/day) · Perimenopausal women with vasomotor symptoms
100 mg26 weeks17
Effect of Pueraria mirifica on vaginal health
2007 · 20 mg Pueraria mirifica · Healthy postmenopausal women aged 45–60 years
20 mg24 weeks—
Effect of Pueraria mirifica on vaginal health
2007 · 30 mg Pueraria mirifica · Healthy postmenopausal women aged 45–60 years
30 mg24 weeks—
Effect of Pueraria mirifica on vaginal health
2007 · 50 mg Pueraria mirifica · Healthy postmenopausal women aged 45–60 years
50 mg24 weeks—
Challenges in the conduct of Thai herbal scientific study: efficacy and safety of phytoestrogen, pueraria mirifica (Kwao Keur Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women
2007 · 50 mg group · Perimenopausal women with climacteric symptoms, including hot flushes and night sweats
50 mg26 weeks—
Challenges in the conduct of Thai herbal scientific study: efficacy and safety of phytoestrogen, pueraria mirifica (Kwao Keur Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women
2007 · 100 mg group · Perimenopausal women with climacteric symptoms, including hot flushes and night sweats
100 mg26 weeks—
Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women
2008 · 20 mg Pueraria mirifica · Healthy postmenopausal women aged 45 to 60 years
20 mg24 weeks—
Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women
2008 · 30 mg Pueraria mirifica · Healthy postmenopausal women aged 45 to 60 years
30 mg24 weeks—
Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women
2008 · 50 mg Pueraria mirifica · Healthy postmenopausal women aged 45 to 60 years
50 mg24 weeks—